Overexpression of Bcl-2 and Mutations in p53 and K-ras in Resected Human Non-Small Cell Lung Cancers

American Journal of Respiratory Cell and Molecular Biology

Volumn 15, Issue 1, 1996, Pages 45-54

  Kitagawa, Yuko ^a   Wong, Fred ^a   Lo, Patrick ^a   Elliott, Mark ^a   Verburgt, Lorraine M ^a   Hogg, James C ^a   Daya, Maleki ^a  

^a The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53; PROTEIN TYROSINE KINASE;

ADENOCARCINOMA; AGED; ARTICLE; CODON; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CODON; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030192063     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.15.1.8679221     Document Type: Article

References (55)

1. Minna, J. D., H. Pass, E. Galstein, and D. Ihde. 1989. Cancer of the lung. In Principles and Practice of Oncology. V. T. Devita, S. Hellman, and S. A. Rosenberg, editors. J. B. Lippincott, Philadelphia. 591-705.
2. Petersen, G. M. 1994. Epidemiology, screening, and prevention of lung cancer. Curr. Opin. Oncol. 6:156-161.
3. Kratzke, R. A., E. Shimizu, and F. J. Kaye. 1992. Oncogenes in human lung cancer. Cancer Treat. Res. 63:61-85.
4. Viallet, J., and J. D. Minna. 1990. Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer. Am. J. Respir. Cell Mol. Biol. 2:225-232.
5. Wyllie, A. H. 1993. Apoptosis. Br. J. Cancer 67:205-208.
6. Korsmeyer, S. J. 1992. Bcl-2 initiates a new category of oncogenes: regulations of cell death. Blood 180:879-886.
7. Tsujimoto, Y., L. R. Finger, J. Yunis, P. C. Nowell, and C. M. Croce. 1984. Cloning of the chromosome breakpoint of neoplastic B cells with t(14;18) chromosome translocation. Science 226:1097-1099.
8. Lu, Q. L., G. Elia, S. Lucas, and J. A. Thomas. 1993. Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int. J. Cancer 53:29-35.
9. McDonnell, T. J., P. Troncoso, S. M. Brisbay, C. Logothetis, L. W. Chung, J. T. Hsieh, S. M. Tu, and M. L. Campbell. 1992. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52:6940-6944.
10. Leek, R. D., L. Kaklamanis, F. Pezzella, K. C. Gatter, and A. L. Harris. 1994. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumors and in situ cancer. Br. J. Cancer 69:135-139.
11. Pezzella, F., H. Turley, I. Kuzu, M. F. Tungekar, M. S. Dunhill, C. B. Pierce, A. Harris, K. C. Gatter, and D. Y. Mason. 1993. bcl-2 protein in non-small-cell lung carcinoma. N. Engl. J. Med. 329:690-694.
12. Reed, J. C., Y. Tsujimoto, S. F. Epstein, M. Cuddy, T. Slabiak, P. C. Nowell, and C. M. Croce. 1989. Regulation of bcl-2 gene expression in lymphoid cell lines containing normal. 18 or t(14;18) chromosomes. Oncogent Res. 4:271-282.
13. Seto, M., U. Jaeger, R. D. Hockett, W. Graninger, S. Bennett, P. Goldman, and S. J. Korsmeyer. 1988. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J. 7:123-131.
14. Bissonnette, R. P., F. Echeverri. A. Mahboubi, and D. R. Green. 1992. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature (London) 359:552-554.
15. Wang, Y., L. Szekely, I. Okan, G. Klein, and K. G. Wiman. 1993. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene 8:3427-3431.
16. Fernandez-Sarabia, M. J., and J. R. Bischoff. 1993. Bcl-2 associates with the ras-related protein R-ras p23. Nature (London) 366:274-275.
17. Moore, J., S. Boswell, R. Hoffman, G. Burgess, and R. Hromas. 1993. Mutant H-ras over-expression inhibits a random apoptotic nuclease in myeloid leukemia cells. Leukemia Res. 17:703-709.
18. Mountain, C. F. 1986. A new international staging system for lung cancer. Chest 89(Suppl. 4):225-234.
19. Cordell, J. L., B. Falini, W. N. Erber, A. K. Ghosh, Z. Abdulaziz, S. MacDonald, K. A. F. Pulford, H. Stein, and D. Y. Mason. 1984. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphates and monoclonal anti-alkaline phosphatase (AP-AAP complexes). J. Histochem. Cytochem. 32:219-229.
20. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Commonly used techniques in molecular cloning. In Molecular Cloning. C. Nalon and M. Ferguson, editors. Cold Spring Harbor Laboratory Press, New York. E-3.
21. Orita, M., Y. Suzuki, T. Sekiya, and K. Hayashi. 1989. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879.
22. Lamb, P., and L. V. Crawford. 1986. Characterization of the human p53 gene. Mol. Cell. Biol. 6:1379-1385.
23. Levi, S., A. U. Ispizua, R. Gill, D. M. Thomas, J. Gilbertson, C. Foster, and C. J. Marshall. 1991. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res. 51:3497-3502.
24. Zambetti, G. P., and A. J. Levine. 1993. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7:855-865.
25. Bos, J. L. 1989. ras oncogenes in human cancer: a review Cancer Res. 49:6482-6489.
26. Fontanini, G., S. Vignati, D. Bigini, A. Mussi, M. Lucchi, C. A. Angelleti, F. Basolo, and G. Bevilacqua. 1995. Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small cell lung cancer. Br. J. Cancer 71:1003-1007.
27. Shaw, P., R. Bovey, S. Tardy, R. Sahli, B. Sordet, and J. Costa. 1992. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89:4495-4499.
28. Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kim-Chi, and M. Oren. 1991. Wild type p53 induces apoptosis of myeloid leukemia cells that is inhibited by interleukin-6. Nature 352:345-347.
29. Lotem, J., and L. Sachs. 1993. Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemia cells. Cell Growth Differ. 4:41-47.
30. Halder, S., M. Negrini, M. Monne, S. Sabbioni, and C. M. Croce. 1994. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res. 54: 2095-2097.
31. Miyashita, T., M. Harigai, M. Hanada, and J. C. Reed. 1994. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54:3131-3135.
32. Miyashita, T., S. Krajewski, M. Krajewski, H.-G. Wang, H.-K. Lin, B. Hoffman, D. Lieberman, and J. C. Reed. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805.
33. Higashima, M., O. Doi, H. Yokouchi, and R. Tateishi. 1995. High prevalence of bcl-2 oncoprotein in small cell lung cancer. Anticancer Res. 15:503-505.
34. Parada, L. F., H. Land, R. A. Weinberg, D. Wolf, and V. Rotter. 1984. Cooperation between gene encoding p53 tumor antigen and ras in cellular transformation. Nature (London) 312:649-651.
35. Buhler-Leclerc, M., A. Gratwohl, and H. P. Senn. 1993. Occurrence of point mutations in p53 gene is not increased in patients with acute myeloid leukaemia carrying an activating N-ras mutation. Br. J. Haematol. 84:443-450.
36. Hollstein, H. C., L. Peri, A. M. Mandard, J. A. Welsh, R. Montesano, R. A. Metcalf, M. Bak, and C. C. Harris. 1991. Genetic analysis of eosophageal tumors from two high incidence geographic areas: frequent p53 base substitutions in the absence of ras mutations. Cancer Res. 51:4102-4103.
37. Teneriello, M. G., M. Ebina, R. I. Linnolia, M. Henry, J. D. Nash, R. C. Park, and M. J. Birrer. 1993. p53 and Ki-ras gene mutation in epithelial ovarian neoplasms. Cancer Res. 53:3103-3108.
38. Lehman, T. A., W. P. Bennet, R. A. Metcalf, J. A. Welsh, J. Ecker, R. M. Modai, S. Ullrich, J. W. Romano, E. Appella, J. R. Testa, B. I. Gerwin, and C. C. Harris. 1991. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res. 51:4090-4096
39. Mitsudomi, T., S. M. Steinberg, M. M. Nau, D. Carbone, D. D'Amico, S. Bodner, H. K. Oie, R. I. Linnoila, J. L. Mulshine, J. D. Minna, and A. F. Gazdar. 1992. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171-180.
40. Carbone, D. P., T. Mitsudomi, I. Chiba, S. Piantaddosii, V. Russch, J. A. Nowak, D. McIntire, D. Slamon, A. Gazdar, and J. Minna. 1994. p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancers: a preliminary report of LCSG 871. Chest 106(Suppl. 6): 377-381.
41. Oliner, J. D., K. W. Kinzler, P. S. Meltzer, D. George, and B. Vogelstein. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (London) 358:80-83.
42. Lane, D. P., and L. V. Crawford. 1979. T antigen is bound to a host protein in SV40-transformed cells. Nature (London) 278:261-263.
43. Linzer, D. I. H., and A. J. Levine. 1979. Characterization of a 55K dalton cellular SV40 tumor antigen in SV40-transformed cells. Cell 17:43-52.
44. Sarnow, P., Y. S. Ho, J. Williams, and A. J. Levine. 1982. Adenovirus E1B-58Kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54Kd cellular protein in transformed cells. Cell 28:387-394.
45. Werness, B. A., A. J. Levine, and P. M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
46. Paquette, R. L., Y. Y. Lee, S. P. Wilcynski, A. Karmakar, M. Kizaki, C. W. Miller, and H. P. Koeffler. 1993. Mutations of p53 and human papillomavirus infection in cervical carcinoma. Cancer 72:1272-1280.
47. Slinger, J. M., J. R. Jenkins, and S. Benchimol. 1993. The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. EMBO J. 12:1029-1037.
48. Lu, X., S. H. Park, T. C. Thompson, and D. P. Lane. 1992. ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation. Cell 70:153-161.
49. Milne, D. M., R. H. Palmer, and D. W. Meek. 1992. Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53. Nucleic Acids Res. 20:5565-5570.
50. Hupp, T. R., D. W. Meek, C. A. Midgley, and D. P. Lane. 1993. Activation of the cryptic DNA binding function of mutant forms of p53. Nucleic Acids Res. 21:3167-3174.
51. Lees-Miller, S. P., K. Sakaguchi, S. J. Ullrich, E. Appella, and C. W. Anderson. 1992. Human DNA-activated protein kinase phosphorylates sermes 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. Biol. 12:5041-5049.
52. Fiscella, M., S. J. Ullrich, N. Zambrano, M. T. Shields, D. Lin, S. P. Lees-Miller, C. W. Anderson, W. E. Mercer, and E. Appella. 1993. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene 8:1519-1528.
53. Wang, H.-G., T. Miyashita, S. Takayama, T. Sato, T. Torigoe, S. Krajewski, S. Tanaka, L. Hovey, J. Troppmair, U. R. Rapp, and J. C. Reed. 1994. Apoptosis regulation by interaction of Bcl-2 protein and Rat-1 kinase. Oncogene 9:2751-2756.
54. Spaargaren, M., G. A. Martin, F. McCormic, M. J. Fernandez-Sarabia, and J. R. Bischoff. 1994. The Ras-related protein R-ras interacts directly with Raf-1 in a GTP-dependent manner. Biochem. J. 300:303-307.
55. Vogelstein, B., E. R. Fearon, S. R. Hamilton, S. E. Kern, A. C. Preisinger, M. Leppert, Y. Nakamura, R. White, A. M. M. Smith, and J. L. Bos. 1988. Genetic alterations during colorectal tumor development. N. Engl. J. Med. 319:525-532.